Bone Health Technologies (BHT) has recently closed a $5 million funding round to enhance care for individuals with low bone density. This round saw contributions from Esplanade Ventures, Berkeley Catalyst Fund, and Terumo Medical, a global leader in medical technology. The funding arrives at a crucial juncture, with BHT nearing the de novo FDA clearance for its Osteoboost vibration wearable. Osteoboost, designed…
Bone Health Technologies, a company at the forefront of bone health solutions, recently announced the FDA clearance of Osteoboost, the first device-based, non-pharmacological prescription treatment for postmenopausal women diagnosed with osteopenia. The wearable belt delivers targeted, calibrated vibration to the lumbar spine and hips, and is designed to reduce the decline in bone strength and density. Osteoboost’s approval introduces a new category…
Healthtech company Bone Health Technologies has recently been awarded its fourth patent, marking a significant milestone in the journey of its product, Osteoboost. The wearable device is at the forefront of addressing osteopenia and osteoporosis in post-menopausal women, two conditions that significantly impact bone health. Osteoboost’s design and innovative approach have made it the first device of its kind to demonstrate a…
OsteoSight, a new technology designed to utilize subtle signals found in routine X-rays for bone mineral density (BMD) assessment, has received a breakthrough device designation from the Food and Drug Administration (FDA). This achievement has the potential to significantly impact the early identification of osteoporosis and the prevention of fragility fractures. Developed by Naitive Technologies, OsteoSight not only provides automated BMD estimates…
San Francisco-based Bone Health Technologies (BHT) has presented pivotal trial data for its novel treatment Osteoboost at the renowned endocrinology conference, Endo 2023. The double-blind study enrolled 126 postmenopausal women with low bone mass, focusing on the effectiveness of Osteoboost in reducing the decline of bone strength and density. The Osteoboost device, which is seeking FDA’s Class 2 Prescription De Novo Approval,…
You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.
Brooklyn-based healthtech startup Wellen is working to combat the high rates of osteoporosis and osteopenia among women with the launch of its personalized, at-home fitness program. With 10 million Americans suffering from osteoporosis and another 44 million with low bone density, Wellen aims to offer a solution for the 54 million individuals affected by this “silent disease.” The program offers personalized fitness…
Bone Health Technologies is a San Francisco-based company that applies science and medical expertise to create better health outcomes for women and men at risk of developing osteoporosis and the associated bone fractures. The company has now announced that the National Institute on Aging (NIA) of the National Institutes of Health (NIH) has awarded the Company $2.7M in a Commercialization Readiness Pilot…
